Boston Scientific Corporation (BSX) recently received the Food and Drug Administration’s (FDA) approval to expand the indication for current-generation INGEVITY+ Pacing Leads. Expanded indication for INGEVITY+ Pacing Leads means thin wires will be placed inside the heart that will be connected to an implantable device. It can be used to include conduction system pacing (CSP) and sensing of the left bundle branch area (LBBA) when connected to a single or dual-chamber pacemaker.The latest FDA approval enhance ...

Boston Scientific (BSX) closed the most recent trading day at $82.52, moving -1.19% from the previous trading session. The stock trailed the S&P 500, which registered a daily gain of 0.03%. Meanwhile, the Dow lost 0.04%, and the Nasdaq, a tech-heavy index, added 0.2%.The the stock of medical device manufacturer has risen by 6.14% in the past month, leading the Medical sector's gain of 2.67% and the S&P 500's gain of 1.54%.Analysts and investors alike will be keeping a close eye on the performance of Boston ...

Boston Scientific Co NYSE: BSX is a global medical device manufacturer that’s seeing a strong influx of investors as shares grind to new all-time highs. The company has a vast portfolio of devices to diagnose and treat medical conditions. The medical technology (medtech) company benefits from the aging population and the chronic diseases that come with it.Get Boston Scientific alerts:Acquiring Silk Road Medical for $1.5 BillionBoston Scientific TodayBSXBoston Scientific$83.51 +0.20 (+0.24%) 52-Week Range$48 ...

Boston Scientific (BSX) closed at $82.94 in the latest trading session, marking a -0.14% move from the prior day. This change lagged the S&P 500's 1.07% gain on the day. At the same time, the Dow added 0.31%, and the tech-heavy Nasdaq gained 2.17%.The medical device manufacturer's stock has climbed by 9.4% in the past month, exceeding the Medical sector's gain of 3.34% and the S&P 500's gain of 2.92%.The upcoming earnings release of Boston Scientific will be of great interest to investors. The company is ex ...

UKRAINE - 2021/06/17: In this photo illustration, a Boston Scientific Corporation logo seen ... [+] displayed on a smartphone and pc screen in the background. (Photo Illustration by Igor Golovniov/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty ImagesBoston Scientific (NYSE: BSX) has more than doubled in value since early January 2021 – jumping from levels of $36 then to around $82 now – vs. an increase of about 45% for the S&P 500 over this period. This can primarily be attribute ...

Boston Scientific Corporation (NYSE:BSX) Wells Fargo 2024 Healthcare Conference September 4, 2024 8:00 AM ET Company Participants Brad Sutton - Chief Medical Officer, AF Solutions Jon Monson - SVP, IR Michael F. Mahoney - Chairman and CEO Conference Call Participants Lawrence Biegelsen - Wells Fargo Securities Lawrence Biegelsen Okay. Good morning and welcome to the 2024 Wells Fargo Healthcare Conference. I'm Larry Biegelsen, the medical device analyst. This our first session at the conference. I'm thrilled ...

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...

Boston Scientific, Inc. (BSX) has obtained a CE Mark for the ACURATE Prime Aortic Valve System — the newest transcatheter aortic valve replacement (TAVR) technology in its structural heart portfolio. The system builds upon the clinical performance of the ACURATE neo2 platform, featuring several enhancements, including an additional valve size, which expands the treatment range to patients with a larger anatomy.The latest development is expected to boost the company’s Interventional Cardiology Therapies, a c ...

MARLBOROUGH, Mass., Aug. 27, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has obtained CE mark for the ACURATE Prime™ Aortic Valve System, the newest transcatheter aortic valve replacement (TAVR) technology in the company's structural heart portfolio. The ACURATE Prime valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a ...

It has been about a month since the last earnings report for Boston Scientific (BSX) . Shares have added about 7.2% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Boston Scientific due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts. Boston Scientific Q2 Earnings Beat ...